<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02668250</url>
  </required_header>
  <id_info>
    <org_study_id>1508190</org_study_id>
    <secondary_id>ANSM</secondary_id>
    <nct_id>NCT02668250</nct_id>
  </id_info>
  <brief_title>Influence of a Multi-parametric Optimization Strategy for General Anesthesia on Postoperative Morbidity and Mortality</brief_title>
  <acronym>OPTI-AGED</acronym>
  <official_title>The OPTI-AGED Study : Influence of a Multi-parametric Optimization Strategy for General Anesthesia on Postoperative Morbidity and Mortality in Elderly Patients. A Randomized, Multicentre, Prospective Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Saint Etienne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ministry of Health, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Saint Etienne</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      With the increasing aging population demographics and life expectancies, the number of very&#xD;
      elderly patients undergoing surgery is rising. Elderly patients constitute an increasingly&#xD;
      large proportion of the high-risk surgical group.&#xD;
&#xD;
      Cardiac complications and postoperative pulmonary complications are equally prevalent and&#xD;
      contribute similarly to morbidity, mortality, and length of hospital stay. Specific&#xD;
      optimization strategy of general anesthesia has been tested in high-risk patients undergoing&#xD;
      major surgery to improve outcomes.&#xD;
&#xD;
      Our hypothesis is that a combined optimization strategy of anesthesia concerning hemodynamic,&#xD;
      ventilation, and depth of anesthesia may improve short- and long- term outcome in elderly&#xD;
      undergoing high risk surgery.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The population is expanding and aging. With the increasing aging population demographics and&#xD;
      life expectancies, the number of very elderly patients (age ≥ 75) undergoing surgery is&#xD;
      rising. Elderly patients constitute an increasingly large proportion of the high-risk&#xD;
      surgical group. In 2010, patients aged 75 yrs and over represented only 2.1% of patients&#xD;
      undergoing high risk surgery in France (PMSI database), but concentrated 27% of in-hospital&#xD;
      deaths.&#xD;
&#xD;
      Cardiac complications and postoperative pulmonary complications are equally prevalent and&#xD;
      contribute similarly to morbidity, mortality, and length of hospital stay. Specific&#xD;
      optimization strategy of general anesthesia has been tested in high-risk patients undergoing&#xD;
      major surgery to improve outcomes. Meta-analyses have demonstrated that goal directed&#xD;
      hemodynamic therapy significantly reduced mortality and surgical complications in high-risk&#xD;
      patients. A lung-protective ventilation strategy in high-risk patients undergoing major&#xD;
      abdominal surgery was associated with improved clinical outcome. Retrospective studies&#xD;
      indicated that a combination of excessive depth of anesthesia, hypotension and low anesthesia&#xD;
      requirement resulted in increased mortality. These approaches of peroperative care remain&#xD;
      discussed in the literature and have also to be incorporated in the common clinical practice.&#xD;
      Moreover, few of these reviews performed a sensitive analysis in the elderly.&#xD;
&#xD;
      Whether a multi-parametric optimization strategy of anesthesia including several specific&#xD;
      interventions will impact the short-term postoperative major morbidity and mortality in&#xD;
      elderly is not known. The addition of depth of anesthesia monitoring to hemodynamic&#xD;
      monitoring and goal directed hemodynamic therapy may improve tissue perfusion by reducing&#xD;
      hemodynamic side effects of anesthetic agents, particularly in elderly where the therapeutic&#xD;
      window of these agents is reduced. The effects of low protective ventilation may also by&#xD;
      additive to the previous measures by reducing the perioperative build-up of oxygen debt. Our&#xD;
      hypothesis is that a combined optimization strategy of anesthesia concerning hemodynamic,&#xD;
      ventilation, and depth of anesthesia may improve short- and long- term outcome in elderly&#xD;
      undergoing high risk surgery.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 3, 2017</start_date>
  <completion_date type="Actual">March 16, 2021</completion_date>
  <primary_completion_date type="Actual">February 5, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of a composite of mortality or major postoperative morbidity.</measure>
    <time_frame>Day 30</time_frame>
    <description>One or more of major postoperative complications : acute kidney injury (defined by Kidney disease : improving Global Outcomes (KDIGO) stage 1 or higher), acute myocardial infarction, heart failure, stroke, development of sepsisand septic shock, acute respiratory failure requiring non-invasive ventilation or intubation, delirium) will be reported in the source folder of the patients, and the mortality will be also focused. The goal of this study is to decrease this incidence.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">2495</enrollment>
  <condition>Coronary; Ischemic</condition>
  <condition>Arrhythmias, Cardiac</condition>
  <condition>Heart Failure</condition>
  <condition>Peripheral Vascular Diseases</condition>
  <condition>Dementia</condition>
  <condition>Stroke</condition>
  <condition>Pulmonary Disease, Chronic Obstructive</condition>
  <condition>Respiratory Insufficiency</condition>
  <condition>Alcoholism</condition>
  <condition>Cancer</condition>
  <condition>Diabetes</condition>
  <condition>Renal Insufficiency</condition>
  <arm_group>
    <arm_group_label>Experimental group : OPTI-AGED</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The OPTI-AGED group will receive a combined optimization strategy of anesthesia concerning hemodynamic, ventilation, and depth of anesthesia.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group :</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The control group will not benefit from the OPTI-AGED intervention but patients will receive the usual care.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>OPTI-AGED</intervention_name>
    <description>OPTI-AGED is composed of a multi-parametric optimization strategy.</description>
    <arm_group_label>Experimental group : OPTI-AGED</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Usual Care</intervention_name>
    <description>Patients receive the usual care.</description>
    <arm_group_label>Control Group :</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All adult patients aged 75 years and over,&#xD;
&#xD;
          -  presenting at least one of the following comorbidities: ischemic coronary disease;&#xD;
             cardiac arrhythmia; congestive heart failure; peripheral vascular disease; dementia;&#xD;
             stroke; chronic obstructive pulmonary disease; chronic respiratory failure; chronic&#xD;
             alcohol abuse; active cancer; diabetes; chronic renal failure A comorbidity index will&#xD;
             be measured by using the modified Charlson Comorbidity Index&#xD;
&#xD;
          -  undergoing elective and emergency surgeries including : femoral head fracture, major&#xD;
             intraperitoneal abdominal surgery lasting &gt; 90 min (excluding elective&#xD;
             cholecystectomy, abdominal wall surgery), vascular surgery (excluding venous surgery&#xD;
             and fistula creation)&#xD;
&#xD;
          -  Patient's or patient's relative signed consent form&#xD;
&#xD;
          -  Affiliation to French social assurance system&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Acute heart failure and acute coronary syndrome&#xD;
&#xD;
          -  Acute respiratory failure, pneumonia&#xD;
&#xD;
          -  Septic shock&#xD;
&#xD;
          -  Delirium&#xD;
&#xD;
          -  Acute stroke&#xD;
&#xD;
          -  Evolutive neuromuscular disorder&#xD;
&#xD;
          -  Thoracic surgery, combined abdominal and thoracic surgery&#xD;
&#xD;
          -  Surgery performed under exclusive regional anesthesia&#xD;
&#xD;
          -  Patients under tutorship or curatorship&#xD;
&#xD;
          -  Refusal to participate&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>75 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>MOLLIEX Serge, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU SAINT ETIENNE</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CHU Amiens - Picardie</name>
      <address>
        <city>Amiens</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU CAEN</name>
      <address>
        <city>Caen</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chu Clermont-Ferrand</name>
      <address>
        <city>Clermont-Ferrand</city>
        <zip>63003</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chu Dijon</name>
      <address>
        <city>Dijon</city>
        <zip>21079</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Médipôle Lyon - Villeurbanne</name>
      <address>
        <city>Décines-Charpieu</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chu Grenoble</name>
      <address>
        <city>Grenoble 9</city>
        <zip>38043</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHRU Lille - Salengro</name>
      <address>
        <city>Lille</city>
        <zip>59000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU LILLE - Huriez</name>
      <address>
        <city>Lille</city>
        <zip>59037</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU LYON</name>
      <address>
        <city>Lyon</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lyon Sud - CHU</name>
      <address>
        <city>Lyon</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chu Marseille La Timone</name>
      <address>
        <city>Marseille</city>
        <zip>13385</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chu Marseille Nord</name>
      <address>
        <city>Marseille</city>
        <zip>13385</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chu Montpellier</name>
      <address>
        <city>Montpellier 5</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chu Nancy</name>
      <address>
        <city>Nancy</city>
        <zip>54035</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de Nantes</name>
      <address>
        <city>Nantes</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU NICE</name>
      <address>
        <city>Nice</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chu Nimes</name>
      <address>
        <city>Nîmes</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ch Paris Beaujon</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ch Paris Bichat</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ch Paris Pitie Salpetriere</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ch Paris Saint Antoine</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ch Saint Louis-Lariboisiere</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chu Poitiers</name>
      <address>
        <city>Poitiers</city>
        <zip>86021</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chu Rennes</name>
      <address>
        <city>Rennes</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chu Rouen</name>
      <address>
        <city>Rouen</city>
        <zip>76031</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chu Saint Etienne</name>
      <address>
        <city>Saint Etienne</city>
        <zip>42100</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hopital Central Strasbourg</name>
      <address>
        <city>Strasbourg</city>
        <zip>67098</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hopital Hautepierre Strasbourg</name>
      <address>
        <city>Strasbourg</city>
        <zip>67098</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chu Toulouse</name>
      <address>
        <city>Toulouse 9</city>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>January 22, 2016</study_first_submitted>
  <study_first_submitted_qc>January 26, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 29, 2016</study_first_posted>
  <last_update_submitted>August 25, 2021</last_update_submitted>
  <last_update_submitted_qc>August 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
    <mesh_term>Respiratory Insufficiency</mesh_term>
    <mesh_term>Renal Insufficiency</mesh_term>
    <mesh_term>Arrhythmias, Cardiac</mesh_term>
    <mesh_term>Vascular Diseases</mesh_term>
    <mesh_term>Peripheral Vascular Diseases</mesh_term>
    <mesh_term>Peripheral Arterial Disease</mesh_term>
    <mesh_term>Pulmonary Valve Insufficiency</mesh_term>
    <mesh_term>Alcoholism</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

